Stay updated on Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.

Latest updates to the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page
- Check3 days agoChange DetectedA new revision entry v3.3.4 was added and the previous v3.3.3 was removed in the Record History for NCT04150965. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2 in the footer, representing minor metadata updates rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page history now shows Revision: v3.3.2 and removes Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the generic government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check74 days agoChange DetectedThe new screenshot shows minor formatting and layout tweaks to the Record History page (e.g., table spacing and header alignment) with no changes to study data, identifiers, or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange Detected- Added a government-operating status notice and a new v3.2.0 version tag. - Removed the previous v3.1.0 tag.SummaryDifference12%

Stay in the know with updates to Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combo Anti-LAG-3/TIGIT Clinical Trial page.